1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neurostimulation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Stimulation Type
6.1 Internal Stimulation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 External Stimulation
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Device Type
7.1 SCS (Spinal Cord Stimulation) Devices
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 DBS (Deep Brain Stimulation) Devices
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 SNS (Sacral Nerve Stimulation) Devices
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 VNS (Vagus Nerve Stimulation) Devices
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 GES (Gastric Electrical Stimulation) Devices
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Transcutaneous Electrical Nerve Stimulation Devices
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Transcranial Magnetic Stimulation Devices
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Others
7.8.1 Market Trends
7.8.2 Market Forecast
8 Market Breakup by Application
8.1 Pain Management
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Epilepsy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Essential Tremors
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Urinary and Fecal Incontinence
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Depression
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Dystonia
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Parkinson’s Disease
8.7.1 Market Trends
8.7.2 Market Forecast
8.8 Others
8.8.1 Market Trends
8.8.2 Market Forecast
9 Market Breakup by End-User
9.1 Rehabilitation Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Medical Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 France
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 United Kingdom
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 Italy
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Spain
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Russia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 Japan
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 India
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 South Korea
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Australia
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Indonesia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
12.1 Overview
12.2 Inbound Logistics
12.3 Operations
12.4 Outbound Logistics
12.5 Marketing and Sales
12.6 Post Sales Services
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biocontrol Medical
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Boston Scientific Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Cyberonics Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Medtronic Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Neuronetics Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Neuropace Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Neurosigma Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Nevro Corporation
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 ST. Jude Medical Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Synapse Biomedical Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer